Skip to main content
. 2018 Feb 26;5(1):149–158. doi: 10.1007/s40744-018-0094-6

Table 2.

Proportion of patients with low disease activity according to DAS28-ESR cutoff at week 52 without post-flare censoring

Patient group ETN (N = 22) PBO (N = 29)
Overall 16/22 (72.7%) 23/29 (79.3%)
Did not flare 9/9 (100%) 8/8 (100%)
Did flarea 7/13 (53.8%) 15/21 (71.4%)

LDA Low disease activity

aAll patients who experienced a flare were administered etanercept rescue treatment